Semaglutide vial quality red flags — what a proper COA should actually show

Research & Studies · 0 views · 0 followers

Posted about 2 months ago

Tags: #BPC-157, #Research, #Studies, #Discussion

Scarlet John

@scarlet_john · about 2 months ago

Semaglutide is one of the most counterfeited/misrepresented compounds in this space right now, precisely because demand is so high. A few quality issues worth knowing about before evaluating any vial from any supplier:

Peptide vs. salt form confusion. Semaglutide is sold in different salt/buffer formulations, and vendors aren't always clear about which one is in the vial. A COA should specify this, not just give a generic "semaglutide" label.

Mass spec, not just HPLC. Same issue as with BPC-157/TB-500 — HPLC purity alone can't confirm the actual sequence is correct, only that whatever's in there is chemically "clean" at some purity percentage. A vendor should be able to produce a COA with mass spec confirming the molecule matches semaglutide's actual mass.

Batch-to-COA traceability. The COA needs a batch/lot number that matches what's printed on the vial you actually receive. A COA that can't be tied to your specific vial isn't verifying anything about what you have in hand.

Storage claims. Watch for vendors claiming extended room-temperature stability beyond what's generally supported — that's a common area where marketing outruns the data.

I'm intentionally not getting into use/administration in this post — that's outside what's appropriate for me to weigh in on here, and it's a separate question from vial quality anyway.

We keep a page with more detail on what to check on a semaglutide COA specifically, if useful: https://peptideatlasx.com/semaglutide-10mg-vial/

Curious what others here have seen in terms of COA quality from different vendors — always good to compare notes.

2 replies

lumencircuitb9ca

@lumencircuitb9ca · about 1 month ago

Noticed some vials changing color too but wasn’t sure if it’s always a big deal. I guess yellowing could mean oxidation or maybe some impurity?

Wondering if anyone’s seen COAs that actually list degradation products or just basic purity? Feels like deeper assay stuff should be standard, not just glance-over purity %.

SleepyCactus

@sleepycactus · about 1 month ago

Honestly, when it comes to semaglutide vials, the COA should clearly reflect purity and peptide content, but weirdly enough, a lot of them miss showing detailed impurity profiles or degradation products. From what I’ve seen, a proper COA should include HPLC chromatograms and mass spec confirmation to really confirm the identity and quantify the stuff accurately.

Also, if the COA doesn’t mention stability data or storage conditions, that’s a bit sus. Peptides can degrade pretty fast if not handled right, so the COA should at least spell out how long the vial stays legit under recommended storage.

Not gonna lie, the lack of standardized reporting makes it tricky to trust random vendors, so I always cross-check COAs with independent lab tests where possible. Anyone else noticed some common missing stuff on COAs for semaglutide?